MedPath

Comparison Between LDCT With DL Recontruction and Standard Dose CT

Active, not recruiting
Conditions
Liver Metastases
Registration Number
NCT05324046
Lead Sponsor
Seoul National University Hospital
Brief Summary

This prospective study aims to perform intra-individual comparison of the image quality between low dose liver CT with deep learning reconstruction and standard dose liver CT with iterative reconstruction in patients with liver metastasis.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
134
Inclusion Criteria
  • patients with underlying malignancy and suspicion of liver metastasis
  • patients with known liver metastasis and on follow-up
  • AND scheduled for contrast enhanced abdomen CT
  • signed informed consent
Exclusion Criteria
  • absolute or relative contra-indication for contrast-enhanced CT
  • diffuse infiltrative liver lesion or multiple (> 10) metastases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
liver lesion conspicuity6 months after the CT scan

graded on a five-point scale (1-5) with higher score indicates a better conscpicuity.

Secondary Outcome Measures
NameTimeMethod
liver lesion detectability6 months after the CT scan

liver lesion detection rate on standard dose CT and low dose CT by blinded reviewers

Trial Locations

Locations (2)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.